This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 1979 Jan;94(1):163-4.

doi: 10.1016/s0022-3476(79)80394-7.

Aminoglycoside clearance in patients with cystic fibrosis

E Finkelstein, K Hall

PMID: 758407
DOI: 10.1016/s0022-3476(79)80394-7

Aminoglycoside clearance in patients with cystic fibrosis

E Finkelstein et al. J Pediatr. 1979 Jan.

. 1979 Jan;94(1):163-4.

doi: 10.1016/s0022-3476(79)80394-7.

Authors

E Finkelstein, K Hall

PMID: 758407
DOI: 10.1016/s0022-3476(79)80394-7

No abstract available

PubMed Disclaimer

Similar articles

Comparative study of the antibacterial activity of amikacin and tobramycin during Pseudomonas pulmonary infection in patients with cystic fibrosis.
Levy J, Baran D, Klastersky J. Levy J, et al. J Antimicrob Chemother. 1982 Sep;10(3):227-34. doi: 10.1093/jac/10.3.227. J Antimicrob Chemother. 1982. PMID: 6815155 Clinical Trial. No abstract available.
The pharmacokinetics of amikacin in children.
Vogelstein B, Kowarski A, Lietman PS. Vogelstein B, et al. J Pediatr. 1977 Aug;91(2):333-9. doi: 10.1016/s0022-3476(77)80847-0. J Pediatr. 1977. PMID: 874697 No abstract available.
Treatment of pediatric infections with amikacin as first-line aminoglycoside.
Shulman ST, Yogev R. Shulman ST, et al. Am J Med. 1985 Jul 15;79(1A):43-50. doi: 10.1016/0002-9343(85)90190-1. Am J Med. 1985. PMID: 4025367
Antimicrobial spectrum, pharmacology, adverse effects, and therapeutic use of amikacin sulfate.
Pien FD, Ho PW. Pien FD, et al. Am J Hosp Pharm. 1981 Jul;38(7):981-9. Am J Hosp Pharm. 1981. PMID: 7020413 Review.
Amikacin.
Meyer RD. Meyer RD. Ann Intern Med. 1981 Sep;95(3):328-32. doi: 10.7326/0003-4819-95-3-328. Ann Intern Med. 1981. PMID: 7023310 Review. No abstract available.

See all similar articles

Cited by

Clinical pharmacokinetics in infants and children. A reappraisal.
Kearns GL, Reed MD. Kearns GL, et al. Clin Pharmacokinet. 1989;17 Suppl 1:29-67. doi: 10.2165/00003088-198900171-00005. Clin Pharmacokinet. 1989. PMID: 2692939 Review.
Influence of the glomerular filtration rate on renal clearance of ceftazidime in cystic fibrosis.
Hedman A, Adan-Abdi Y, Alvan G, Strandvik B, Arvidsson A. Hedman A, et al. Clin Pharmacokinet. 1988 Jul;15(1):57-65. doi: 10.2165/00003088-198815010-00005. Clin Pharmacokinet. 1988. PMID: 3042246
Increased oral bioavailability of ciprofloxacin in cystic fibrosis patients.
Christensson BA, Nilsson-Ehle I, Ljungberg B, Lindblad A, Malmborg AS, Hjelte L, Strandvik B. Christensson BA, et al. Antimicrob Agents Chemother. 1992 Nov;36(11):2512-7. doi: 10.1128/AAC.36.11.2512. Antimicrob Agents Chemother. 1992. PMID: 1489195 Free PMC article.
Sedation with Propofol for Bronchoscopy in Cystic Fibrosis Lung Transplant Recipients.
Ho C, Hayes D Jr, Khosravi M, Splaingard ML, Tumin D, Lloyd EA. Ho C, et al. Lung. 2018 Aug;196(4):435-439. doi: 10.1007/s00408-018-0119-5. Epub 2018 May 24. Lung. 2018. PMID: 29797070
Pharmacokinetics of amikacin in cystic fibrosis: a study of bronchial diffusion.
Autret E, Marchand S, Breteau M, Grenier B. Autret E, et al. Eur J Clin Pharmacol. 1986;31(1):79-83. doi: 10.1007/BF00870991. Eur J Clin Pharmacol. 1986. PMID: 3780832

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Medical
- Genetic Alliance